Drug profile · INN
bepridil hydrochloride
VASCOR
bepridil hydrochloride (VASCOR) is a voltage-gated calcium channel blocker. Route of administration: oral. Current US regulatory status: approved.
Drug details — bepridil hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
bepridil hydrochloride (VASCOR) is a voltage-gated calcium channel blocker. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Voltage-gated calcium channel blocker
Primary target: Voltage-gated calcium channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is bepridil hydrochloride?
bepridil hydrochloride (VASCOR) is a voltage-gated calcium channel blocker. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for bepridil hydrochloride?
VASCOR is a marketed brand name for bepridil hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of bepridil hydrochloride?
bepridil hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.